Global Immuno-oncology Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Immunotherapy is treatment that uses a certain part of a person’s immune system to fight diseases which is done by stimulating one’s own immune system to work harder to attack cancer cells or by giving immune system components, such as man-made immune system proteins. Immunotherapy includes treatments that work in different ways. Some boost the body’s immune system in a very general way and others help train the immune system to attack cancer cells specifically.
According to our (Global Info Research) latest study, the global Immuno-oncology Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Immuno-oncology Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Immuno-oncology Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Immuno-oncology Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Immuno-oncology Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Immuno-oncology Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immuno-oncology Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immuno-oncology Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Inc, AstraZeneca, Plc, Bristol-Myers Squibb, Celgene Corporation and Eli Lilly and Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Immuno-oncology Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Immuno-oncology Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immuno-oncology Drugs, with price, sales, revenue and global market share of Immuno-oncology Drugs from 2018 to 2023.
Chapter 3, the Immuno-oncology Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immuno-oncology Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Immuno-oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immuno-oncology Drugs.
Chapter 14 and 15, to describe Immuno-oncology Drugs sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Immuno-oncology Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Immuno-oncology Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Immuno-oncology Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Immuno-oncology Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Immuno-oncology Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Immuno-oncology Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immuno-oncology Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immuno-oncology Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Inc, AstraZeneca, Plc, Bristol-Myers Squibb, Celgene Corporation and Eli Lilly and Company, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Immuno-oncology Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Immune Checkpoint Inhibitors
- Immune System Modulators
- Cancer Vaccines
- Oncolytic Virus
- Others
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Amgen, Inc
- AstraZeneca, Plc
- Bristol-Myers Squibb
- Celgene Corporation
- Eli Lilly and Company
- Merck & Co.
- Hoffmann-La Roche AG
- Johnson & Johnson
- Novartis International AG
- AbbVie, Inc.
- Pfizer Inc.
- Sanofi S.A.
- EMD Serono, Inc.
- Gilead Sciences Inc.
- Prometheus Therapeutics & Diagnostics
- Aduro BioTech
- Galena Biopharma
- Bavarian Nordic
- Celldex Therapeutics
- ImmunoCellular Therapeutics
- Incyte
- Dendreon Corporation
- Agilent Technologies Inc.
- Agenus Inc.
- Enzo Biochem, Inc.
- Lonza Group
- Bio-Rad Laboratories, Inc.
- Avantor, Inc.
- Spring Bank Pharmaceuticals, Inc.
- Ferring Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Immuno-oncology Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immuno-oncology Drugs, with price, sales, revenue and global market share of Immuno-oncology Drugs from 2018 to 2023.
Chapter 3, the Immuno-oncology Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immuno-oncology Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Immuno-oncology Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immuno-oncology Drugs.
Chapter 14 and 15, to describe Immuno-oncology Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Immuno-oncology Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Immuno-oncology Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Immune Checkpoint Inhibitors
1.3.3 Immune System Modulators
1.3.4 Cancer Vaccines
1.3.5 Oncolytic Virus
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Immuno-oncology Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Ambulatory Surgical Centers
1.5 Global Immuno-oncology Drugs Market Size & Forecast
1.5.1 Global Immuno-oncology Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Immuno-oncology Drugs Sales Quantity (2018-2029)
1.5.3 Global Immuno-oncology Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Amgen, Inc
2.1.1 Amgen, Inc Details
2.1.2 Amgen, Inc Major Business
2.1.3 Amgen, Inc Immuno-oncology Drugs Product and Services
2.1.4 Amgen, Inc Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amgen, Inc Recent Developments/Updates
2.2 AstraZeneca, Plc
2.2.1 AstraZeneca, Plc Details
2.2.2 AstraZeneca, Plc Major Business
2.2.3 AstraZeneca, Plc Immuno-oncology Drugs Product and Services
2.2.4 AstraZeneca, Plc Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca, Plc Recent Developments/Updates
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Product and Services
2.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bristol-Myers Squibb Recent Developments/Updates
2.4 Celgene Corporation
2.4.1 Celgene Corporation Details
2.4.2 Celgene Corporation Major Business
2.4.3 Celgene Corporation Immuno-oncology Drugs Product and Services
2.4.4 Celgene Corporation Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Celgene Corporation Recent Developments/Updates
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Immuno-oncology Drugs Product and Services
2.5.4 Eli Lilly and Company Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly and Company Recent Developments/Updates
2.6 Merck & Co.
2.6.1 Merck & Co. Details
2.6.2 Merck & Co. Major Business
2.6.3 Merck & Co. Immuno-oncology Drugs Product and Services
2.6.4 Merck & Co. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck & Co. Recent Developments/Updates
2.7 Hoffmann-La Roche AG
2.7.1 Hoffmann-La Roche AG Details
2.7.2 Hoffmann-La Roche AG Major Business
2.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Product and Services
2.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hoffmann-La Roche AG Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Immuno-oncology Drugs Product and Services
2.8.4 Johnson & Johnson Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Johnson & Johnson Recent Developments/Updates
2.9 Novartis International AG
2.9.1 Novartis International AG Details
2.9.2 Novartis International AG Major Business
2.9.3 Novartis International AG Immuno-oncology Drugs Product and Services
2.9.4 Novartis International AG Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Novartis International AG Recent Developments/Updates
2.10 AbbVie, Inc.
2.10.1 AbbVie, Inc. Details
2.10.2 AbbVie, Inc. Major Business
2.10.3 AbbVie, Inc. Immuno-oncology Drugs Product and Services
2.10.4 AbbVie, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AbbVie, Inc. Recent Developments/Updates
2.11 Pfizer Inc.
2.11.1 Pfizer Inc. Details
2.11.2 Pfizer Inc. Major Business
2.11.3 Pfizer Inc. Immuno-oncology Drugs Product and Services
2.11.4 Pfizer Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer Inc. Recent Developments/Updates
2.12 Sanofi S.A.
2.12.1 Sanofi S.A. Details
2.12.2 Sanofi S.A. Major Business
2.12.3 Sanofi S.A. Immuno-oncology Drugs Product and Services
2.12.4 Sanofi S.A. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sanofi S.A. Recent Developments/Updates
2.13 EMD Serono, Inc.
2.13.1 EMD Serono, Inc. Details
2.13.2 EMD Serono, Inc. Major Business
2.13.3 EMD Serono, Inc. Immuno-oncology Drugs Product and Services
2.13.4 EMD Serono, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 EMD Serono, Inc. Recent Developments/Updates
2.14 Gilead Sciences Inc.
2.14.1 Gilead Sciences Inc. Details
2.14.2 Gilead Sciences Inc. Major Business
2.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Product and Services
2.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Gilead Sciences Inc. Recent Developments/Updates
2.15 Prometheus Therapeutics & Diagnostics
2.15.1 Prometheus Therapeutics & Diagnostics Details
2.15.2 Prometheus Therapeutics & Diagnostics Major Business
2.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product and Services
2.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Prometheus Therapeutics & Diagnostics Recent Developments/Updates
2.16 Aduro BioTech
2.16.1 Aduro BioTech Details
2.16.2 Aduro BioTech Major Business
2.16.3 Aduro BioTech Immuno-oncology Drugs Product and Services
2.16.4 Aduro BioTech Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Aduro BioTech Recent Developments/Updates
2.17 Galena Biopharma
2.17.1 Galena Biopharma Details
2.17.2 Galena Biopharma Major Business
2.17.3 Galena Biopharma Immuno-oncology Drugs Product and Services
2.17.4 Galena Biopharma Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Galena Biopharma Recent Developments/Updates
2.18 Bavarian Nordic
2.18.1 Bavarian Nordic Details
2.18.2 Bavarian Nordic Major Business
2.18.3 Bavarian Nordic Immuno-oncology Drugs Product and Services
2.18.4 Bavarian Nordic Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Bavarian Nordic Recent Developments/Updates
2.19 Celldex Therapeutics
2.19.1 Celldex Therapeutics Details
2.19.2 Celldex Therapeutics Major Business
2.19.3 Celldex Therapeutics Immuno-oncology Drugs Product and Services
2.19.4 Celldex Therapeutics Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Celldex Therapeutics Recent Developments/Updates
2.20 ImmunoCellular Therapeutics
2.20.1 ImmunoCellular Therapeutics Details
2.20.2 ImmunoCellular Therapeutics Major Business
2.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Product and Services
2.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 ImmunoCellular Therapeutics Recent Developments/Updates
2.21 Incyte
2.21.1 Incyte Details
2.21.2 Incyte Major Business
2.21.3 Incyte Immuno-oncology Drugs Product and Services
2.21.4 Incyte Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Incyte Recent Developments/Updates
2.22 Dendreon Corporation
2.22.1 Dendreon Corporation Details
2.22.2 Dendreon Corporation Major Business
2.22.3 Dendreon Corporation Immuno-oncology Drugs Product and Services
2.22.4 Dendreon Corporation Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Dendreon Corporation Recent Developments/Updates
2.23 Agilent Technologies Inc.
2.23.1 Agilent Technologies Inc. Details
2.23.2 Agilent Technologies Inc. Major Business
2.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Product and Services
2.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Agilent Technologies Inc. Recent Developments/Updates
2.24 Agenus Inc.
2.24.1 Agenus Inc. Details
2.24.2 Agenus Inc. Major Business
2.24.3 Agenus Inc. Immuno-oncology Drugs Product and Services
2.24.4 Agenus Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Agenus Inc. Recent Developments/Updates
2.25 Enzo Biochem, Inc.
2.25.1 Enzo Biochem, Inc. Details
2.25.2 Enzo Biochem, Inc. Major Business
2.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Product and Services
2.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Enzo Biochem, Inc. Recent Developments/Updates
2.26 Lonza Group
2.26.1 Lonza Group Details
2.26.2 Lonza Group Major Business
2.26.3 Lonza Group Immuno-oncology Drugs Product and Services
2.26.4 Lonza Group Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Lonza Group Recent Developments/Updates
2.27 Bio-Rad Laboratories, Inc.
2.27.1 Bio-Rad Laboratories, Inc. Details
2.27.2 Bio-Rad Laboratories, Inc. Major Business
2.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product and Services
2.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
2.28 Avantor, Inc.
2.28.1 Avantor, Inc. Details
2.28.2 Avantor, Inc. Major Business
2.28.3 Avantor, Inc. Immuno-oncology Drugs Product and Services
2.28.4 Avantor, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.28.5 Avantor, Inc. Recent Developments/Updates
2.29 Spring Bank Pharmaceuticals, Inc.
2.29.1 Spring Bank Pharmaceuticals, Inc. Details
2.29.2 Spring Bank Pharmaceuticals, Inc. Major Business
2.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product and Services
2.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.29.5 Spring Bank Pharmaceuticals, Inc. Recent Developments/Updates
2.30 Ferring Pharmaceuticals
2.30.1 Ferring Pharmaceuticals Details
2.30.2 Ferring Pharmaceuticals Major Business
2.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Product and Services
2.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.30.5 Ferring Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMMUNO-ONCOLOGY DRUGS BY MANUFACTURER
3.1 Global Immuno-oncology Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Immuno-oncology Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Immuno-oncology Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Immuno-oncology Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Immuno-oncology Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Immuno-oncology Drugs Manufacturer Market Share in 2022
3.5 Immuno-oncology Drugs Market: Overall Company Footprint Analysis
3.5.1 Immuno-oncology Drugs Market: Region Footprint
3.5.2 Immuno-oncology Drugs Market: Company Product Type Footprint
3.5.3 Immuno-oncology Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Immuno-oncology Drugs Market Size by Region
4.1.1 Global Immuno-oncology Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Immuno-oncology Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Immuno-oncology Drugs Average Price by Region (2018-2029)
4.2 North America Immuno-oncology Drugs Consumption Value (2018-2029)
4.3 Europe Immuno-oncology Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Immuno-oncology Drugs Consumption Value (2018-2029)
4.5 South America Immuno-oncology Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Immuno-oncology Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
5.2 Global Immuno-oncology Drugs Consumption Value by Type (2018-2029)
5.3 Global Immuno-oncology Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
6.2 Global Immuno-oncology Drugs Consumption Value by Application (2018-2029)
6.3 Global Immuno-oncology Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
7.2 North America Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
7.3 North America Immuno-oncology Drugs Market Size by Country
7.3.1 North America Immuno-oncology Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Immuno-oncology Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Immuno-oncology Drugs Market Size by Country
8.3.1 Europe Immuno-oncology Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Immuno-oncology Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Immuno-oncology Drugs Market Size by Region
9.3.1 Asia-Pacific Immuno-oncology Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Immuno-oncology Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
10.2 South America Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
10.3 South America Immuno-oncology Drugs Market Size by Country
10.3.1 South America Immuno-oncology Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Immuno-oncology Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Immuno-oncology Drugs Market Size by Country
11.3.1 Middle East & Africa Immuno-oncology Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Immuno-oncology Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Immuno-oncology Drugs Market Drivers
12.2 Immuno-oncology Drugs Market Restraints
12.3 Immuno-oncology Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Immuno-oncology Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immuno-oncology Drugs
13.3 Immuno-oncology Drugs Production Process
13.4 Immuno-oncology Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immuno-oncology Drugs Typical Distributors
14.3 Immuno-oncology Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Immuno-oncology Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Immuno-oncology Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Immune Checkpoint Inhibitors
1.3.3 Immune System Modulators
1.3.4 Cancer Vaccines
1.3.5 Oncolytic Virus
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Immuno-oncology Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Ambulatory Surgical Centers
1.5 Global Immuno-oncology Drugs Market Size & Forecast
1.5.1 Global Immuno-oncology Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Immuno-oncology Drugs Sales Quantity (2018-2029)
1.5.3 Global Immuno-oncology Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Amgen, Inc
2.1.1 Amgen, Inc Details
2.1.2 Amgen, Inc Major Business
2.1.3 Amgen, Inc Immuno-oncology Drugs Product and Services
2.1.4 Amgen, Inc Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amgen, Inc Recent Developments/Updates
2.2 AstraZeneca, Plc
2.2.1 AstraZeneca, Plc Details
2.2.2 AstraZeneca, Plc Major Business
2.2.3 AstraZeneca, Plc Immuno-oncology Drugs Product and Services
2.2.4 AstraZeneca, Plc Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca, Plc Recent Developments/Updates
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Product and Services
2.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bristol-Myers Squibb Recent Developments/Updates
2.4 Celgene Corporation
2.4.1 Celgene Corporation Details
2.4.2 Celgene Corporation Major Business
2.4.3 Celgene Corporation Immuno-oncology Drugs Product and Services
2.4.4 Celgene Corporation Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Celgene Corporation Recent Developments/Updates
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Immuno-oncology Drugs Product and Services
2.5.4 Eli Lilly and Company Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly and Company Recent Developments/Updates
2.6 Merck & Co.
2.6.1 Merck & Co. Details
2.6.2 Merck & Co. Major Business
2.6.3 Merck & Co. Immuno-oncology Drugs Product and Services
2.6.4 Merck & Co. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck & Co. Recent Developments/Updates
2.7 Hoffmann-La Roche AG
2.7.1 Hoffmann-La Roche AG Details
2.7.2 Hoffmann-La Roche AG Major Business
2.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Product and Services
2.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hoffmann-La Roche AG Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Immuno-oncology Drugs Product and Services
2.8.4 Johnson & Johnson Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Johnson & Johnson Recent Developments/Updates
2.9 Novartis International AG
2.9.1 Novartis International AG Details
2.9.2 Novartis International AG Major Business
2.9.3 Novartis International AG Immuno-oncology Drugs Product and Services
2.9.4 Novartis International AG Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Novartis International AG Recent Developments/Updates
2.10 AbbVie, Inc.
2.10.1 AbbVie, Inc. Details
2.10.2 AbbVie, Inc. Major Business
2.10.3 AbbVie, Inc. Immuno-oncology Drugs Product and Services
2.10.4 AbbVie, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AbbVie, Inc. Recent Developments/Updates
2.11 Pfizer Inc.
2.11.1 Pfizer Inc. Details
2.11.2 Pfizer Inc. Major Business
2.11.3 Pfizer Inc. Immuno-oncology Drugs Product and Services
2.11.4 Pfizer Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Pfizer Inc. Recent Developments/Updates
2.12 Sanofi S.A.
2.12.1 Sanofi S.A. Details
2.12.2 Sanofi S.A. Major Business
2.12.3 Sanofi S.A. Immuno-oncology Drugs Product and Services
2.12.4 Sanofi S.A. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sanofi S.A. Recent Developments/Updates
2.13 EMD Serono, Inc.
2.13.1 EMD Serono, Inc. Details
2.13.2 EMD Serono, Inc. Major Business
2.13.3 EMD Serono, Inc. Immuno-oncology Drugs Product and Services
2.13.4 EMD Serono, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 EMD Serono, Inc. Recent Developments/Updates
2.14 Gilead Sciences Inc.
2.14.1 Gilead Sciences Inc. Details
2.14.2 Gilead Sciences Inc. Major Business
2.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Product and Services
2.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Gilead Sciences Inc. Recent Developments/Updates
2.15 Prometheus Therapeutics & Diagnostics
2.15.1 Prometheus Therapeutics & Diagnostics Details
2.15.2 Prometheus Therapeutics & Diagnostics Major Business
2.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product and Services
2.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Prometheus Therapeutics & Diagnostics Recent Developments/Updates
2.16 Aduro BioTech
2.16.1 Aduro BioTech Details
2.16.2 Aduro BioTech Major Business
2.16.3 Aduro BioTech Immuno-oncology Drugs Product and Services
2.16.4 Aduro BioTech Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Aduro BioTech Recent Developments/Updates
2.17 Galena Biopharma
2.17.1 Galena Biopharma Details
2.17.2 Galena Biopharma Major Business
2.17.3 Galena Biopharma Immuno-oncology Drugs Product and Services
2.17.4 Galena Biopharma Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Galena Biopharma Recent Developments/Updates
2.18 Bavarian Nordic
2.18.1 Bavarian Nordic Details
2.18.2 Bavarian Nordic Major Business
2.18.3 Bavarian Nordic Immuno-oncology Drugs Product and Services
2.18.4 Bavarian Nordic Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Bavarian Nordic Recent Developments/Updates
2.19 Celldex Therapeutics
2.19.1 Celldex Therapeutics Details
2.19.2 Celldex Therapeutics Major Business
2.19.3 Celldex Therapeutics Immuno-oncology Drugs Product and Services
2.19.4 Celldex Therapeutics Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Celldex Therapeutics Recent Developments/Updates
2.20 ImmunoCellular Therapeutics
2.20.1 ImmunoCellular Therapeutics Details
2.20.2 ImmunoCellular Therapeutics Major Business
2.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Product and Services
2.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 ImmunoCellular Therapeutics Recent Developments/Updates
2.21 Incyte
2.21.1 Incyte Details
2.21.2 Incyte Major Business
2.21.3 Incyte Immuno-oncology Drugs Product and Services
2.21.4 Incyte Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Incyte Recent Developments/Updates
2.22 Dendreon Corporation
2.22.1 Dendreon Corporation Details
2.22.2 Dendreon Corporation Major Business
2.22.3 Dendreon Corporation Immuno-oncology Drugs Product and Services
2.22.4 Dendreon Corporation Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Dendreon Corporation Recent Developments/Updates
2.23 Agilent Technologies Inc.
2.23.1 Agilent Technologies Inc. Details
2.23.2 Agilent Technologies Inc. Major Business
2.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Product and Services
2.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Agilent Technologies Inc. Recent Developments/Updates
2.24 Agenus Inc.
2.24.1 Agenus Inc. Details
2.24.2 Agenus Inc. Major Business
2.24.3 Agenus Inc. Immuno-oncology Drugs Product and Services
2.24.4 Agenus Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Agenus Inc. Recent Developments/Updates
2.25 Enzo Biochem, Inc.
2.25.1 Enzo Biochem, Inc. Details
2.25.2 Enzo Biochem, Inc. Major Business
2.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Product and Services
2.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Enzo Biochem, Inc. Recent Developments/Updates
2.26 Lonza Group
2.26.1 Lonza Group Details
2.26.2 Lonza Group Major Business
2.26.3 Lonza Group Immuno-oncology Drugs Product and Services
2.26.4 Lonza Group Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Lonza Group Recent Developments/Updates
2.27 Bio-Rad Laboratories, Inc.
2.27.1 Bio-Rad Laboratories, Inc. Details
2.27.2 Bio-Rad Laboratories, Inc. Major Business
2.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product and Services
2.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
2.28 Avantor, Inc.
2.28.1 Avantor, Inc. Details
2.28.2 Avantor, Inc. Major Business
2.28.3 Avantor, Inc. Immuno-oncology Drugs Product and Services
2.28.4 Avantor, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.28.5 Avantor, Inc. Recent Developments/Updates
2.29 Spring Bank Pharmaceuticals, Inc.
2.29.1 Spring Bank Pharmaceuticals, Inc. Details
2.29.2 Spring Bank Pharmaceuticals, Inc. Major Business
2.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product and Services
2.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.29.5 Spring Bank Pharmaceuticals, Inc. Recent Developments/Updates
2.30 Ferring Pharmaceuticals
2.30.1 Ferring Pharmaceuticals Details
2.30.2 Ferring Pharmaceuticals Major Business
2.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Product and Services
2.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.30.5 Ferring Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMMUNO-ONCOLOGY DRUGS BY MANUFACTURER
3.1 Global Immuno-oncology Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Immuno-oncology Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Immuno-oncology Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Immuno-oncology Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Immuno-oncology Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Immuno-oncology Drugs Manufacturer Market Share in 2022
3.5 Immuno-oncology Drugs Market: Overall Company Footprint Analysis
3.5.1 Immuno-oncology Drugs Market: Region Footprint
3.5.2 Immuno-oncology Drugs Market: Company Product Type Footprint
3.5.3 Immuno-oncology Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Immuno-oncology Drugs Market Size by Region
4.1.1 Global Immuno-oncology Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Immuno-oncology Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Immuno-oncology Drugs Average Price by Region (2018-2029)
4.2 North America Immuno-oncology Drugs Consumption Value (2018-2029)
4.3 Europe Immuno-oncology Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Immuno-oncology Drugs Consumption Value (2018-2029)
4.5 South America Immuno-oncology Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Immuno-oncology Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
5.2 Global Immuno-oncology Drugs Consumption Value by Type (2018-2029)
5.3 Global Immuno-oncology Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
6.2 Global Immuno-oncology Drugs Consumption Value by Application (2018-2029)
6.3 Global Immuno-oncology Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
7.2 North America Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
7.3 North America Immuno-oncology Drugs Market Size by Country
7.3.1 North America Immuno-oncology Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Immuno-oncology Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Immuno-oncology Drugs Market Size by Country
8.3.1 Europe Immuno-oncology Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Immuno-oncology Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Immuno-oncology Drugs Market Size by Region
9.3.1 Asia-Pacific Immuno-oncology Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Immuno-oncology Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
10.2 South America Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
10.3 South America Immuno-oncology Drugs Market Size by Country
10.3.1 South America Immuno-oncology Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Immuno-oncology Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Immuno-oncology Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Immuno-oncology Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Immuno-oncology Drugs Market Size by Country
11.3.1 Middle East & Africa Immuno-oncology Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Immuno-oncology Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Immuno-oncology Drugs Market Drivers
12.2 Immuno-oncology Drugs Market Restraints
12.3 Immuno-oncology Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Immuno-oncology Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immuno-oncology Drugs
13.3 Immuno-oncology Drugs Production Process
13.4 Immuno-oncology Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immuno-oncology Drugs Typical Distributors
14.3 Immuno-oncology Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Immuno-oncology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Immuno-oncology Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Amgen, Inc Basic Information, Manufacturing Base and Competitors
Table 4. Amgen, Inc Major Business
Table 5. Amgen, Inc Immuno-oncology Drugs Product and Services
Table 6. Amgen, Inc Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Amgen, Inc Recent Developments/Updates
Table 8. AstraZeneca, Plc Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca, Plc Major Business
Table 10. AstraZeneca, Plc Immuno-oncology Drugs Product and Services
Table 11. AstraZeneca, Plc Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca, Plc Recent Developments/Updates
Table 13. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb Major Business
Table 15. Bristol-Myers Squibb Immuno-oncology Drugs Product and Services
Table 16. Bristol-Myers Squibb Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bristol-Myers Squibb Recent Developments/Updates
Table 18. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 19. Celgene Corporation Major Business
Table 20. Celgene Corporation Immuno-oncology Drugs Product and Services
Table 21. Celgene Corporation Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Celgene Corporation Recent Developments/Updates
Table 23. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company Major Business
Table 25. Eli Lilly and Company Immuno-oncology Drugs Product and Services
Table 26. Eli Lilly and Company Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly and Company Recent Developments/Updates
Table 28. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 29. Merck & Co. Major Business
Table 30. Merck & Co. Immuno-oncology Drugs Product and Services
Table 31. Merck & Co. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Merck & Co. Recent Developments/Updates
Table 33. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 34. Hoffmann-La Roche AG Major Business
Table 35. Hoffmann-La Roche AG Immuno-oncology Drugs Product and Services
Table 36. Hoffmann-La Roche AG Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hoffmann-La Roche AG Recent Developments/Updates
Table 38. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 39. Johnson & Johnson Major Business
Table 40. Johnson & Johnson Immuno-oncology Drugs Product and Services
Table 41. Johnson & Johnson Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Johnson & Johnson Recent Developments/Updates
Table 43. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis International AG Major Business
Table 45. Novartis International AG Immuno-oncology Drugs Product and Services
Table 46. Novartis International AG Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Novartis International AG Recent Developments/Updates
Table 48. AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table 49. AbbVie, Inc. Major Business
Table 50. AbbVie, Inc. Immuno-oncology Drugs Product and Services
Table 51. AbbVie, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. AbbVie, Inc. Recent Developments/Updates
Table 53. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Inc. Major Business
Table 55. Pfizer Inc. Immuno-oncology Drugs Product and Services
Table 56. Pfizer Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Pfizer Inc. Recent Developments/Updates
Table 58. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 59. Sanofi S.A. Major Business
Table 60. Sanofi S.A. Immuno-oncology Drugs Product and Services
Table 61. Sanofi S.A. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sanofi S.A. Recent Developments/Updates
Table 63. EMD Serono, Inc. Basic Information, Manufacturing Base and Competitors
Table 64. EMD Serono, Inc. Major Business
Table 65. EMD Serono, Inc. Immuno-oncology Drugs Product and Services
Table 66. EMD Serono, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. EMD Serono, Inc. Recent Developments/Updates
Table 68. Gilead Sciences Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Gilead Sciences Inc. Major Business
Table 70. Gilead Sciences Inc. Immuno-oncology Drugs Product and Services
Table 71. Gilead Sciences Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Gilead Sciences Inc. Recent Developments/Updates
Table 73. Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base and Competitors
Table 74. Prometheus Therapeutics & Diagnostics Major Business
Table 75. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product and Services
Table 76. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Prometheus Therapeutics & Diagnostics Recent Developments/Updates
Table 78. Aduro BioTech Basic Information, Manufacturing Base and Competitors
Table 79. Aduro BioTech Major Business
Table 80. Aduro BioTech Immuno-oncology Drugs Product and Services
Table 81. Aduro BioTech Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Aduro BioTech Recent Developments/Updates
Table 83. Galena Biopharma Basic Information, Manufacturing Base and Competitors
Table 84. Galena Biopharma Major Business
Table 85. Galena Biopharma Immuno-oncology Drugs Product and Services
Table 86. Galena Biopharma Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Galena Biopharma Recent Developments/Updates
Table 88. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 89. Bavarian Nordic Major Business
Table 90. Bavarian Nordic Immuno-oncology Drugs Product and Services
Table 91. Bavarian Nordic Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Bavarian Nordic Recent Developments/Updates
Table 93. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 94. Celldex Therapeutics Major Business
Table 95. Celldex Therapeutics Immuno-oncology Drugs Product and Services
Table 96. Celldex Therapeutics Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Celldex Therapeutics Recent Developments/Updates
Table 98. ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 99. ImmunoCellular Therapeutics Major Business
Table 100. ImmunoCellular Therapeutics Immuno-oncology Drugs Product and Services
Table 101. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. ImmunoCellular Therapeutics Recent Developments/Updates
Table 103. Incyte Basic Information, Manufacturing Base and Competitors
Table 104. Incyte Major Business
Table 105. Incyte Immuno-oncology Drugs Product and Services
Table 106. Incyte Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Incyte Recent Developments/Updates
Table 108. Dendreon Corporation Basic Information, Manufacturing Base and Competitors
Table 109. Dendreon Corporation Major Business
Table 110. Dendreon Corporation Immuno-oncology Drugs Product and Services
Table 111. Dendreon Corporation Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Dendreon Corporation Recent Developments/Updates
Table 113. Agilent Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Agilent Technologies Inc. Major Business
Table 115. Agilent Technologies Inc. Immuno-oncology Drugs Product and Services
Table 116. Agilent Technologies Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 117. Agilent Technologies Inc. Recent Developments/Updates
Table 118. Agenus Inc. Basic Information, Manufacturing Base and Competitors
Table 119. Agenus Inc. Major Business
Table 120. Agenus Inc. Immuno-oncology Drugs Product and Services
Table 121. Agenus Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 122. Agenus Inc. Recent Developments/Updates
Table 123. Enzo Biochem, Inc. Basic Information, Manufacturing Base and Competitors
Table 124. Enzo Biochem, Inc. Major Business
Table 125. Enzo Biochem, Inc. Immuno-oncology Drugs Product and Services
Table 126. Enzo Biochem, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 127. Enzo Biochem, Inc. Recent Developments/Updates
Table 128. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 129. Lonza Group Major Business
Table 130. Lonza Group Immuno-oncology Drugs Product and Services
Table 131. Lonza Group Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 132. Lonza Group Recent Developments/Updates
Table 133. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 134. Bio-Rad Laboratories, Inc. Major Business
Table 135. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product and Services
Table 136. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 138. Avantor, Inc. Basic Information, Manufacturing Base and Competitors
Table 139. Avantor, Inc. Major Business
Table 140. Avantor, Inc. Immuno-oncology Drugs Product and Services
Table 141. Avantor, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Avantor, Inc. Recent Developments/Updates
Table 143. Spring Bank Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 144. Spring Bank Pharmaceuticals, Inc.Major Business
Table 145. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product and Services
Table 146. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 147. Spring Bank Pharmaceuticals, Inc. Recent Developments/Updates
Table 148. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 149. Ferring Pharmaceuticals Major Business
Table 150. Ferring Pharmaceuticals Immuno-oncology Drugs Product and Services
Table 151. Ferring Pharmaceuticals Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 152. Ferring Pharmaceuticals Recent Developments/Updates
Table 153. Global Immuno-oncology Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 154. Global Immuno-oncology Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 155. Global Immuno-oncology Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 156. Market Position of Manufacturers in Immuno-oncology Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 157. Head Office and Immuno-oncology Drugs Production Site of Key Manufacturer
Table 158. Immuno-oncology Drugs Market: Company Product Type Footprint
Table 159. Immuno-oncology Drugs Market: Company Product Application Footprint
Table 160. Immuno-oncology Drugs New Market Entrants and Barriers to Market Entry
Table 161. Immuno-oncology Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 162. Global Immuno-oncology Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 163. Global Immuno-oncology Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 164. Global Immuno-oncology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 165. Global Immuno-oncology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 166. Global Immuno-oncology Drugs Average Price by Region (2018-2023) & (USD/Unit)
Table 167. Global Immuno-oncology Drugs Average Price by Region (2024-2029) & (USD/Unit)
Table 168. Global Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 169. Global Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 170. Global Immuno-oncology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 171. Global Immuno-oncology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 172. Global Immuno-oncology Drugs Average Price by Type (2018-2023) & (USD/Unit)
Table 173. Global Immuno-oncology Drugs Average Price by Type (2024-2029) & (USD/Unit)
Table 174. Global Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 175. Global Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 176. Global Immuno-oncology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 177. Global Immuno-oncology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 178. Global Immuno-oncology Drugs Average Price by Application (2018-2023) & (USD/Unit)
Table 179. Global Immuno-oncology Drugs Average Price by Application (2024-2029) & (USD/Unit)
Table 180. North America Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 181. North America Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 182. North America Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 183. North America Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 184. North America Immuno-oncology Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 185. North America Immuno-oncology Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 186. North America Immuno-oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 187. North America Immuno-oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 188. Europe Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 189. Europe Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 190. Europe Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 191. Europe Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 192. Europe Immuno-oncology Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 193. Europe Immuno-oncology Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 194. Europe Immuno-oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 195. Europe Immuno-oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 196. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 197. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 198. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 199. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 200. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 201. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 202. Asia-Pacific Immuno-oncology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 203. Asia-Pacific Immuno-oncology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 204. South America Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 205. South America Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 206. South America Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 207. South America Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 208. South America Immuno-oncology Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 209. South America Immuno-oncology Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 210. South America Immuno-oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 211. South America Immuno-oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 212. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 213. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 214. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 215. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 216. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 217. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 218. Middle East & Africa Immuno-oncology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 219. Middle East & Africa Immuno-oncology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 220. Immuno-oncology Drugs Raw Material
Table 221. Key Manufacturers of Immuno-oncology Drugs Raw Materials
Table 222. Immuno-oncology Drugs Typical Distributors
Table 223. Immuno-oncology Drugs Typical Customers
Table 1. Global Immuno-oncology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Immuno-oncology Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Amgen, Inc Basic Information, Manufacturing Base and Competitors
Table 4. Amgen, Inc Major Business
Table 5. Amgen, Inc Immuno-oncology Drugs Product and Services
Table 6. Amgen, Inc Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Amgen, Inc Recent Developments/Updates
Table 8. AstraZeneca, Plc Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca, Plc Major Business
Table 10. AstraZeneca, Plc Immuno-oncology Drugs Product and Services
Table 11. AstraZeneca, Plc Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca, Plc Recent Developments/Updates
Table 13. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb Major Business
Table 15. Bristol-Myers Squibb Immuno-oncology Drugs Product and Services
Table 16. Bristol-Myers Squibb Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bristol-Myers Squibb Recent Developments/Updates
Table 18. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 19. Celgene Corporation Major Business
Table 20. Celgene Corporation Immuno-oncology Drugs Product and Services
Table 21. Celgene Corporation Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Celgene Corporation Recent Developments/Updates
Table 23. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company Major Business
Table 25. Eli Lilly and Company Immuno-oncology Drugs Product and Services
Table 26. Eli Lilly and Company Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly and Company Recent Developments/Updates
Table 28. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 29. Merck & Co. Major Business
Table 30. Merck & Co. Immuno-oncology Drugs Product and Services
Table 31. Merck & Co. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Merck & Co. Recent Developments/Updates
Table 33. Hoffmann-La Roche AG Basic Information, Manufacturing Base and Competitors
Table 34. Hoffmann-La Roche AG Major Business
Table 35. Hoffmann-La Roche AG Immuno-oncology Drugs Product and Services
Table 36. Hoffmann-La Roche AG Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hoffmann-La Roche AG Recent Developments/Updates
Table 38. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 39. Johnson & Johnson Major Business
Table 40. Johnson & Johnson Immuno-oncology Drugs Product and Services
Table 41. Johnson & Johnson Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Johnson & Johnson Recent Developments/Updates
Table 43. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis International AG Major Business
Table 45. Novartis International AG Immuno-oncology Drugs Product and Services
Table 46. Novartis International AG Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Novartis International AG Recent Developments/Updates
Table 48. AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table 49. AbbVie, Inc. Major Business
Table 50. AbbVie, Inc. Immuno-oncology Drugs Product and Services
Table 51. AbbVie, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. AbbVie, Inc. Recent Developments/Updates
Table 53. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Inc. Major Business
Table 55. Pfizer Inc. Immuno-oncology Drugs Product and Services
Table 56. Pfizer Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Pfizer Inc. Recent Developments/Updates
Table 58. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 59. Sanofi S.A. Major Business
Table 60. Sanofi S.A. Immuno-oncology Drugs Product and Services
Table 61. Sanofi S.A. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Sanofi S.A. Recent Developments/Updates
Table 63. EMD Serono, Inc. Basic Information, Manufacturing Base and Competitors
Table 64. EMD Serono, Inc. Major Business
Table 65. EMD Serono, Inc. Immuno-oncology Drugs Product and Services
Table 66. EMD Serono, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. EMD Serono, Inc. Recent Developments/Updates
Table 68. Gilead Sciences Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Gilead Sciences Inc. Major Business
Table 70. Gilead Sciences Inc. Immuno-oncology Drugs Product and Services
Table 71. Gilead Sciences Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Gilead Sciences Inc. Recent Developments/Updates
Table 73. Prometheus Therapeutics & Diagnostics Basic Information, Manufacturing Base and Competitors
Table 74. Prometheus Therapeutics & Diagnostics Major Business
Table 75. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product and Services
Table 76. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Prometheus Therapeutics & Diagnostics Recent Developments/Updates
Table 78. Aduro BioTech Basic Information, Manufacturing Base and Competitors
Table 79. Aduro BioTech Major Business
Table 80. Aduro BioTech Immuno-oncology Drugs Product and Services
Table 81. Aduro BioTech Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Aduro BioTech Recent Developments/Updates
Table 83. Galena Biopharma Basic Information, Manufacturing Base and Competitors
Table 84. Galena Biopharma Major Business
Table 85. Galena Biopharma Immuno-oncology Drugs Product and Services
Table 86. Galena Biopharma Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Galena Biopharma Recent Developments/Updates
Table 88. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 89. Bavarian Nordic Major Business
Table 90. Bavarian Nordic Immuno-oncology Drugs Product and Services
Table 91. Bavarian Nordic Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Bavarian Nordic Recent Developments/Updates
Table 93. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 94. Celldex Therapeutics Major Business
Table 95. Celldex Therapeutics Immuno-oncology Drugs Product and Services
Table 96. Celldex Therapeutics Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Celldex Therapeutics Recent Developments/Updates
Table 98. ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 99. ImmunoCellular Therapeutics Major Business
Table 100. ImmunoCellular Therapeutics Immuno-oncology Drugs Product and Services
Table 101. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. ImmunoCellular Therapeutics Recent Developments/Updates
Table 103. Incyte Basic Information, Manufacturing Base and Competitors
Table 104. Incyte Major Business
Table 105. Incyte Immuno-oncology Drugs Product and Services
Table 106. Incyte Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Incyte Recent Developments/Updates
Table 108. Dendreon Corporation Basic Information, Manufacturing Base and Competitors
Table 109. Dendreon Corporation Major Business
Table 110. Dendreon Corporation Immuno-oncology Drugs Product and Services
Table 111. Dendreon Corporation Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Dendreon Corporation Recent Developments/Updates
Table 113. Agilent Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Agilent Technologies Inc. Major Business
Table 115. Agilent Technologies Inc. Immuno-oncology Drugs Product and Services
Table 116. Agilent Technologies Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 117. Agilent Technologies Inc. Recent Developments/Updates
Table 118. Agenus Inc. Basic Information, Manufacturing Base and Competitors
Table 119. Agenus Inc. Major Business
Table 120. Agenus Inc. Immuno-oncology Drugs Product and Services
Table 121. Agenus Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 122. Agenus Inc. Recent Developments/Updates
Table 123. Enzo Biochem, Inc. Basic Information, Manufacturing Base and Competitors
Table 124. Enzo Biochem, Inc. Major Business
Table 125. Enzo Biochem, Inc. Immuno-oncology Drugs Product and Services
Table 126. Enzo Biochem, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 127. Enzo Biochem, Inc. Recent Developments/Updates
Table 128. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 129. Lonza Group Major Business
Table 130. Lonza Group Immuno-oncology Drugs Product and Services
Table 131. Lonza Group Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 132. Lonza Group Recent Developments/Updates
Table 133. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 134. Bio-Rad Laboratories, Inc. Major Business
Table 135. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product and Services
Table 136. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 138. Avantor, Inc. Basic Information, Manufacturing Base and Competitors
Table 139. Avantor, Inc. Major Business
Table 140. Avantor, Inc. Immuno-oncology Drugs Product and Services
Table 141. Avantor, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Avantor, Inc. Recent Developments/Updates
Table 143. Spring Bank Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 144. Spring Bank Pharmaceuticals, Inc.Major Business
Table 145. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product and Services
Table 146. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 147. Spring Bank Pharmaceuticals, Inc. Recent Developments/Updates
Table 148. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 149. Ferring Pharmaceuticals Major Business
Table 150. Ferring Pharmaceuticals Immuno-oncology Drugs Product and Services
Table 151. Ferring Pharmaceuticals Immuno-oncology Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 152. Ferring Pharmaceuticals Recent Developments/Updates
Table 153. Global Immuno-oncology Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 154. Global Immuno-oncology Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 155. Global Immuno-oncology Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 156. Market Position of Manufacturers in Immuno-oncology Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 157. Head Office and Immuno-oncology Drugs Production Site of Key Manufacturer
Table 158. Immuno-oncology Drugs Market: Company Product Type Footprint
Table 159. Immuno-oncology Drugs Market: Company Product Application Footprint
Table 160. Immuno-oncology Drugs New Market Entrants and Barriers to Market Entry
Table 161. Immuno-oncology Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 162. Global Immuno-oncology Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 163. Global Immuno-oncology Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 164. Global Immuno-oncology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 165. Global Immuno-oncology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 166. Global Immuno-oncology Drugs Average Price by Region (2018-2023) & (USD/Unit)
Table 167. Global Immuno-oncology Drugs Average Price by Region (2024-2029) & (USD/Unit)
Table 168. Global Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 169. Global Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 170. Global Immuno-oncology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 171. Global Immuno-oncology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 172. Global Immuno-oncology Drugs Average Price by Type (2018-2023) & (USD/Unit)
Table 173. Global Immuno-oncology Drugs Average Price by Type (2024-2029) & (USD/Unit)
Table 174. Global Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 175. Global Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 176. Global Immuno-oncology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 177. Global Immuno-oncology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 178. Global Immuno-oncology Drugs Average Price by Application (2018-2023) & (USD/Unit)
Table 179. Global Immuno-oncology Drugs Average Price by Application (2024-2029) & (USD/Unit)
Table 180. North America Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 181. North America Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 182. North America Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 183. North America Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 184. North America Immuno-oncology Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 185. North America Immuno-oncology Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 186. North America Immuno-oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 187. North America Immuno-oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 188. Europe Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 189. Europe Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 190. Europe Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 191. Europe Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 192. Europe Immuno-oncology Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 193. Europe Immuno-oncology Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 194. Europe Immuno-oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 195. Europe Immuno-oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 196. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 197. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 198. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 199. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 200. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 201. Asia-Pacific Immuno-oncology Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 202. Asia-Pacific Immuno-oncology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 203. Asia-Pacific Immuno-oncology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 204. South America Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 205. South America Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 206. South America Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 207. South America Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 208. South America Immuno-oncology Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 209. South America Immuno-oncology Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 210. South America Immuno-oncology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 211. South America Immuno-oncology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 212. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 213. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 214. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 215. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 216. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 217. Middle East & Africa Immuno-oncology Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 218. Middle East & Africa Immuno-oncology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 219. Middle East & Africa Immuno-oncology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 220. Immuno-oncology Drugs Raw Material
Table 221. Key Manufacturers of Immuno-oncology Drugs Raw Materials
Table 222. Immuno-oncology Drugs Typical Distributors
Table 223. Immuno-oncology Drugs Typical Customers
LIST OF FIGURES
Figure 1. Immuno-oncology Drugs Picture
Figure 2. Global Immuno-oncology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Immuno-oncology Drugs Consumption Value Market Share by Type in 2022
Figure 4. Immune Checkpoint Inhibitors Examples
Figure 5. Immune System Modulators Examples
Figure 6. Cancer Vaccines Examples
Figure 7. Oncolytic Virus Examples
Figure 8. Others Examples
Figure 9. Global Immuno-oncology Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Immuno-oncology Drugs Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Examples
Figure 12. Clinics Examples
Figure 13. Ambulatory Surgical Centers Examples
Figure 14. Global Immuno-oncology Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Immuno-oncology Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Immuno-oncology Drugs Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Immuno-oncology Drugs Average Price (2018-2029) & (USD/Unit)
Figure 18. Global Immuno-oncology Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Immuno-oncology Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Immuno-oncology Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Immuno-oncology Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Immuno-oncology Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Immuno-oncology Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Immuno-oncology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Immuno-oncology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Immuno-oncology Drugs Average Price by Type (2018-2029) & (USD/Unit)
Figure 33. Global Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Immuno-oncology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Immuno-oncology Drugs Average Price by Application (2018-2029) & (USD/Unit)
Figure 36. North America Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Immuno-oncology Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Immuno-oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Immuno-oncology Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Immuno-oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Immuno-oncology Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Immuno-oncology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 56. China Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Immuno-oncology Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Immuno-oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Immuno-oncology Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Immuno-oncology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Immuno-oncology Drugs Market Drivers
Figure 77. Immuno-oncology Drugs Market Restraints
Figure 78. Immuno-oncology Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Immuno-oncology Drugs in 2022
Figure 81. Manufacturing Process Analysis of Immuno-oncology Drugs
Figure 82. Immuno-oncology Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Immuno-oncology Drugs Picture
Figure 2. Global Immuno-oncology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Immuno-oncology Drugs Consumption Value Market Share by Type in 2022
Figure 4. Immune Checkpoint Inhibitors Examples
Figure 5. Immune System Modulators Examples
Figure 6. Cancer Vaccines Examples
Figure 7. Oncolytic Virus Examples
Figure 8. Others Examples
Figure 9. Global Immuno-oncology Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Immuno-oncology Drugs Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Examples
Figure 12. Clinics Examples
Figure 13. Ambulatory Surgical Centers Examples
Figure 14. Global Immuno-oncology Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Immuno-oncology Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Immuno-oncology Drugs Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Immuno-oncology Drugs Average Price (2018-2029) & (USD/Unit)
Figure 18. Global Immuno-oncology Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Immuno-oncology Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Immuno-oncology Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Immuno-oncology Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Immuno-oncology Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Immuno-oncology Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Immuno-oncology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Immuno-oncology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Immuno-oncology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Immuno-oncology Drugs Average Price by Type (2018-2029) & (USD/Unit)
Figure 33. Global Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Immuno-oncology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Immuno-oncology Drugs Average Price by Application (2018-2029) & (USD/Unit)
Figure 36. North America Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Immuno-oncology Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Immuno-oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Immuno-oncology Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Immuno-oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Immuno-oncology Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Immuno-oncology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 56. China Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Immuno-oncology Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Immuno-oncology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Immuno-oncology Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Immuno-oncology Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Immuno-oncology Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Immuno-oncology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Immuno-oncology Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Immuno-oncology Drugs Market Drivers
Figure 77. Immuno-oncology Drugs Market Restraints
Figure 78. Immuno-oncology Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Immuno-oncology Drugs in 2022
Figure 81. Manufacturing Process Analysis of Immuno-oncology Drugs
Figure 82. Immuno-oncology Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
